New Horizon Health Limited (6606.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap6.48B
Enterprise Value5.59B
P/E Ratio-64.1
PEG Ratio-0.03
Price/Sales Ratio7.14
Price/Book Ratio2.39
Enterprise/Revenue5.99
Enterprise/EBITDA-99.6

Fiscal Year

Fiscal YearDecember 31, 2022
Most Recent QuarterJune 30, 2023

Profitability

Profit Margin-0.1
Operating Margin-0.21
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.04

Income Statement

Revenue764.96M
Revenue/Share1.83
Gross Profit646.17M
EBITDA-45.97M
Net Income-79.24M
Diluted EPS-0.19

Balance Sheet

Total Cash1.68B
Total Cash/Share3.21
Total Debt448M
Total Debt/Equity0.12
Current Ratio8.8
Book Value Per Share5.09

Price History

52-Week Change-47.14
52-Week High21.95
52-Week Low13.76
Moving Average 50 Days14.14
Moving Average 200 Days14.14

Statistics

Average Volume0
Shares Outstanding448.75M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD